Starpharma & Okamoto Industries Inc
Medical applications and devices are an expanding area of Australia-Japan business. The ASX-listed Starpharma’s core technology is “built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and structure, and well-suited to pharmaceutical and medical uses.” Starpharma has announced it's...